Opioid abuse and corporate social responsibility

Jing Jia and Zhongtian Li

Finance Research Letters, 2022, vol. 49, issue C

Abstract: This study examines the effect of adopting restrictive opioid prescribing laws (i.e., opioid laws) on corporate social responsibility (CSR) performance. Using the staggered adoption of opioid laws by US states, we find that the adoption of opioid laws leads to higher CSR performance. Moreover, the positive impact of opioid laws on firms’ CSR performance is more pronounced in states with stronger enforcement of opioid laws. Given the impacts of opioid abuse in the US, our findings should be of great interest to investors, directors, managers, and public policy makers.

Keywords: Opioid; Opioid prescribing laws; Corporate social responsibility (search for similar items in EconPapers)
JEL-codes: G30 I18 M14 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S1544612322003397
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:finlet:v:49:y:2022:i:c:s1544612322003397

DOI: 10.1016/j.frl.2022.103115

Access Statistics for this article

Finance Research Letters is currently edited by R. Gençay

More articles in Finance Research Letters from Elsevier
Bibliographic data for series maintained by Catherine Liu ().